No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs529359 |
chr11:100993846-100993847 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs576112069 |
chr11:100993902-100993903 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs189218972 |
chr11:100993924-100993925 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs544050938 |
chr11:100993956-100993957 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs118124681 |
chr11:100993984-100993985 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs529713662 |
chr11:100994002-100994003 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs35370108 |
chr11:100994070-100994071 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs560335468 |
chr11:100994072-100994073 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs532134812 |
chr11:100994090-100994091 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs552236186 |
chr11:100994102-100994103 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs74551360 |
chr11:100994112-100994113 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs557256629 |
chr11:100994121-100994122 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs575414388 |
chr11:100994122-100994123 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs192505204 |
chr11:100994138-100994139 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs182395405 |
chr11:100994142-100994143 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs568643376 |
chr11:100994194-100994195 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs34485330 |
chr11:100994204-100994205 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs534171182 |
chr11:100994223-100994224 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs553841395 |
chr11:100994282-100994283 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs576959946 |
chr11:100994290-100994291 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs186725606 |
chr11:100994362-100994363 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs556545798 |
chr11:100994365-100994366 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs138732328 |
chr11:100994369-100994370 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs564601846 |
chr11:100994415-100994416 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs117112396 |
chr11:100994420-100994421 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs559605894 |
chr11:100994446-100994447 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs34350624 |
chr11:100994458-100994459 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs191283063 |
chr11:100994467-100994468 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs542888111 |
chr11:100994472-100994473 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs374318142 |
chr11:100994523-100994524 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs540472437 |
chr11:100994568-100994569 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs571827530 |
chr11:100994619-100994620 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs374700872 |
chr11:100994626-100994627 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs481775 |
chr11:100994675-100994676 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
35 |
rs34445416 |
chr11:100994749-100994750 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs34762352 |
chr11:100994823-100994824 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs562513574 |
chr11:100994834-100994835 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs144843450 |
chr11:100994839-100994840 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs35595684 |
chr11:100994845-100994846 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs35416901 |
chr11:100994849-100994850 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs582691 |
chr11:100994866-100994867 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs580512 |
chr11:100994882-100994883 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs570586629 |
chr11:100994899-100994900 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs148177226 |
chr11:100994940-100994941 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs564011901 |
chr11:100994988-100994989 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs377219616 |
chr11:100995019-100995020 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs484682 |
chr11:100995021-100995022 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs564143137 |
chr11:100995040-100995041 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs535525279 |
chr11:100995133-100995134 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs142936731 |
chr11:100995139-100995140 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|